Advancing the standard of care in patients with type 2 diabetes and established cardiovascular disease: how can we improve patient outcomes? .
Congress Presentation
About the speakers
Professor Nikolaus Marx
Professor Darren Keith McGuire
Doctor Jacob Allan Udell
Professor Subodh Verma
Professor Naveed Sattar
5 more presentations in this session
Welcome and introduction - Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice.
Speaker: Professor N. Marx (Aachen, DE)
Evidence-based approaches to reducing premature cardiovascular mortality in patients with type 2 diabetes and established cardiovascular disease.
Speaker: Professor D. McGuire (Dallas, US)
Applying evidence in practice: appropriate use of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in the cardiology clinic.
Speaker: Doctor J. Udell (Toronto, CA) Professor N. Sattar (Glasgow, GB)
Exploring the effects of SGLT2 inhibition in ongoing trials.
Speaker: Professor S. Verma (Toronto, CA)
Summary and close - Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice.
Speaker: Professor N. Marx (Aachen, DE)
Access the full session
Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice
About the event
ESC 365 is supported by
